Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Non-randomized Phase IIa Trial to Evaluate Safety of Early Intervention in Asymptomatic Subarachnoid Neurocysticercosis

NCT03950037 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT03950037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03950037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Non-randomized Phase IIa Trial to Evaluate Safety of Early Intervention in Asymptomatic Subarachnoid Neurocysticercosis
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Withdrawn
Start date
January 1, 2022
Completion date
April 30, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid neurocysticercosis